Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

Juul reaches settlement with Chicago for nearly $24 million

Published 03/10/2023, 04:19 PM
Updated 03/10/2023, 04:22 PM
© Reuters. FILE PHOTO: Flavored disposable e-cigarettes are seen in this illustration taken July 18, 2022. REUTERS/Shannon Stapleton

(Reuters) - The Chicago mayor's office said on Friday a $23.8 million settlement has been reached with Juul Labs Inc over claims that the e-cigarette maker deceptively marketed its products and for selling vaping products to underage users.

The once red-hot vaping company is currently facing thousands of lawsuits filed across the United States over claims on its marketing practices and for contributing to a rising tobacco use amongst youth.

In the settlement, Chicago said Juul has denied and continues to deny any wrongdoing and liability in connection with the design, manufacture, production, advertisement, marketing, distribution, sale, use, and performance of its products.

A Juul spokesman said in an emailed statement that the settlement with Chicago is another step in the company's ongoing commitment to resolve issues from the past and transition adult smokers away from combustible cigarettes while combating underage use of its products.

According to the settlement, the company has agreed to pay the city $2.8 million within 30 days of the execution of the agreement.

Chicago would receive an additional $21 million payment later this year under the current schedule and may potentially receive up to $750,000 additional, court-awarded payments, the Chicago mayor's office said.

Altria Group (NYSE:MO) Inc, which had a stake in Juul valued at $12.8 billion in 2018, on Monday exchanged its investment in Juul, last valued at $250 million, for some of the vaping company's heated tobacco intellectual property.

Altria said it would buy startup NJOY Holdings Inc for about $2.75 billion in cash, betting that NJOY will prove to be an easier way to tap the e-cigarette category since six of the company's products have received full approval from the U.S. Food and Drug Administration.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Latest comments

greed to save their mismanaged pension funds. don't pay it
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.